Patient Access to drug treatment therapies; and drug cost and drug pricing reform. Oversight of the pharmaceutical industry and drug pricing. Monitoring policies as they relate to PBMs Monitor issues related to the FY2026 budget process
2025 · 3rd Quarter (July 1 - Sep 30)
ABBVIE, INC.
Filed by FEDERAL STREET STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 21, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- FEDERAL STREET STRATEGIES, LLC
- Client
- ABBVIE, INC.
- Filing UUID
- acda91c7-d03e-460e-8700-8da9e61f2c16
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Medicare Part D policies. Monitoring Policies related to the 340b program. Issues related to the implementation of the Inflation Reduction Act Monitor issues related to the FY2026 budget process
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.